Last update:

Cardiology news

ACC issues decision pathway for postpartum cardiovascular care

A new Expert Consensus Decision Pathway by the American College of Cardiology (ACC) provides recommended strategies for improving postpartum care for individuals with and at risk for short- and long-term cardiovascular disease ...

Both heart chambers are more severely affected in atrial fibrillation than previously thought, study reveals

New research findings from the University Medical Center Göttingen (UMG) show that both atria undergo profound changes in cases of persistent atrial fibrillation. Until now, the left atrium was considered the primary site ...

Scientists uncover protein that could help failing hearts

Researchers have identified a key protein that may help failing hearts regain function, offering new insight into why some hearts recover while others do not. The discovery comes from studying patients treated with left ventricular ...

MRI technique enhances valve disease evaluation

A new cardiac magnetic resonance imaging-based measurement may improve how physicians assess a common heart valve condition, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings ...

AI flags heart risks in breast cancer patients

UBC Okanagan researchers, working with scientists at BC Cancer–Kelowna, have developed a groundbreaking AI model that can help identify breast cancer patients who may face a double-threat—that of cancer and cardiovascular ...

Why managing expectations matters in chronic pain treatment

In a 2026 study I conducted with colleagues on people with peripheral arterial disease, one participant described how leg pain had disrupted his golf for years. It forced him to stop mid-round, shake his leg and apologize ...

New cholesterol guidelines aim to stop heart disease earlier

Doctors should consider treating high cholesterol much earlier and more aggressively than they have in the past, according to a new perspective by Weill Cornell Medicine, New York-Presbyterian and Yale School of Medicine ...

Age does not appear to drive cardiovascular risk in pregnancy

Underlying cardiovascular risk, rather than older age, drives complications such as venous thromboembolism, cardiomyopathy and heart failure during pregnancy, according to new Weill Cornell Medicine research. The findings ...

Researchers find important clue to healthy heartbeats

A tiny region in a little-known muscle protein may hold the key to a healthy, steady heartbeat, as well as possible clues to future treatment of devastating heart ailments. Washington State University researchers have found ...

Gut microbes can affect the heart via the brain

Hypertension and heart failure affect millions worldwide. Yet in many patients, doctors cannot fully explain why the heart becomes stiff and struggles to relax—a condition known as diastolic dysfunction.

Molecular switch for treatment after heart attack discovered

More than 300,000 people suffer a heart attack in Germany every year. The heart muscle is then no longer supplied with sufficient blood and oxygen, and part of the tissue dies and scars. Unlike the liver, the heart of an ...

The skinny on fat: 'How to eat to avoid chronic diseases'

This is the first celebration of Heart Month (it comes every February) since the release of the updated dietary guidelines for Americans. The new recommendations are meant to represent the most current scientific evidence ...

Unmasking the real sugar threat to kids during heart month

While most parents know to limit candy, the true danger of sugar in a child's diet is often hidden in plain sight. A growing body of research reveals that excessive sugar consumption in childhood is linked to a frightening ...

Discovery could improve immune checkpoint inhibitor safety

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar brand names. However, ...

What's next for GLP-1s?

Now that GLP-1 drugs have revolutionized how millions of Americans treat obesity and Type 2 diabetes, scientists are exploring the benefits of using the drugs for a host of other chronic diseases—many with few treatment options—such ...